| SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | 21q11 | 0.255 | -0.031 | 0.524
|
| LILRA5 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 | 19q13.4 | 0.252 | -0.117 | 0.016
|
| GNB4 | guanine nucleotide binding protein (G protein), beta polypeptide 4 | 3q27.1 | 0.251 | -0.067 | 0.169
|
| GRIPAP1 | GRIP1 associated protein 1 | Xp11.23 | 0.25 | 0.383 | 7.32e-17
|
| CTPS2 | CTP synthase 2 | Xp22 | 0.248 | 0.402 | 0
|
| KDM5C | lysine (K)-specific demethylase 5C | Xp11.22-p11.21 | 0.245 | 0.414 | 0
|
| ZNF674 | zinc finger protein 674 | Xp11.3 | 0.242 | 0.314 | 3.79e-11
|
| TBC1D25 | TBC1 domain family, member 25 | Xp11.23 | 0.241 | 0.247 | 2.67e-07
|
| TRAPPC2 | trafficking protein particle complex 2 | Xp22 | 0.239 | 0.375 | 9.18e-16
|
| FPR1 | formyl peptide receptor 1 | 19q13.41 | 0.237 | -0.124 | 0.0103
|
| C5AR1 | complement component 5a receptor 1 | 19q13.3-q13.4 | 0.236 | -0.095 | 0.0493
|
| SRGN | serglycin | 10q22.1 | 0.234 | -0.046 | 0.343
|
| IL2RA | interleukin 2 receptor, alpha | 10p15-p14 | 0.234 | -0.001 | 0.978
|
| SLA | Src-like-adaptor | 8q24.22 | 0.23 | -0.053 | 0.274
|
| OFD1 | oral-facial-digital syndrome 1 | Xp22 | 0.228 | 0.382 | 1.38e-16
|
| HDAC6 | histone deacetylase 6 | Xp11.23 | 0.222 | 0.357 | 3.39e-14
|
| CCDC22 | coiled-coil domain containing 22 | Xp11.23 | 0.222 | 0.351 | 1.06e-13
|
| PHKA2 | phosphorylase kinase, alpha 2 (liver) | Xp22.2-p22.1 | 0.22 | 0.34 | 6.5e-13
|
| PRPS2 | phosphoribosyl pyrophosphate synthetase 2 | Xp22.2 | 0.217 | 0.364 | 9.75e-15
|
| EIF1AX | eukaryotic translation initiation factor 1A, X-linked | Xp22.13 | 0.216 | 0.263 | 3.87e-08
|
| ZRSR2 | zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2 | Xp22.1 | 0.216 | 0.39 | 0
|
| EIF2S3 | eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa | Xp22.2-p22.1 | 0.216 | 0.371 | 2.3e-15
|
| FUNDC1 | FUN14 domain containing 1 | Xp11.4 | 0.215 | 0.369 | 3.79e-15
|
| SYAP1 | synapse associated protein 1 | Xp22.31 | 0.214 | 0.367 | 5.96e-15
|
| CA5BP1 | carbonic anhydrase VB pseudogene 1 | Xp22.2 | 0.213 | 0.36 | 1.96e-14
|
| THEMIS2 | thymocyte selection associated family member 2 | 1p35.2 | 0.212 | -0.019 | 0.69
|
| UBE2A | ubiquitin-conjugating enzyme E2A | Xq24 | 0.21 | 0.239 | 6.11e-07
|
| FTSJ1 | FtsJ RNA methyltransferase homolog 1 (E. coli) | Xp11.23 | 0.209 | 0.331 | 3.18e-12
|
| WDR45 | WD repeat domain 45 | Xp11.23 | 0.209 | 0.387 | 0
|
| FMR1 | fragile X mental retardation 1 | Xq27.3 | 0.208 | 0.18 | 0.000189
|
| HCCS | holocytochrome c synthase | Xp22 | 0.208 | 0.405 | 0
|
| PIGA | phosphatidylinositol glycan anchor biosynthesis, class A | Xp22.1 | 0.205 | 0.348 | 1.72e-13
|
| GABPB1 | GA binding protein transcription factor, beta subunit 1 | 15q21.2 | 0.204 | 0.266 | 2.85e-08
|
| NLGN4X | neuroligin 4, X-linked | Xp22.33 | 0.204 | 0.036 | 0.461
|
| MROH6 | maestro heat-like repeat family member 6 | 8q24.3 | 0.204 | -0.124 | 0.0107
|
| SLC14A1 | solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | 18q11-q12 | 0.203 | 0.124 | 0.0105
|
| HSD17B10 | hydroxysteroid (17-beta) dehydrogenase 10 | Xp11.2 | 0.202 | 0.312 | 5.33e-11
|
| CSTF3 | cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa | 11p13 | 0.2 | 0.272 | 1.35e-08
|
| ZNF570 | zinc finger protein 570 | 19q13.12 | 0.2 | -0.092 | 0.0574
|
| LRRC45 | leucine rich repeat containing 45 | 17q25.3 | 0.2 | 0.038 | 0.428
|
| CEP44 | centrosomal protein 44kDa | 4q34 | 0.199 | 0.045 | 0.35
|
| PCCA | propionyl CoA carboxylase, alpha polypeptide | 13q32 | 0.199 | -0.132 | 0.00647
|
| RND1 | Rho family GTPase 1 | 12q12 | 0.198 | -0.082 | 0.0902
|
| APOO | apolipoprotein O | Xp22.11 | 0.198 | 0.293 | 8.63e-10
|
| RAB9A | RAB9A, member RAS oncogene family | Xp22.2 | 0.197 | 0.329 | 3.87e-12
|
| OTUD5 | OTU deubiquitinase 5 | Xp11.23 | 0.195 | 0.368 | 4.2e-15
|
| IL18R1 | interleukin 18 receptor 1 | 2q12 | 0.195 | 0.128 | 0.00801
|
| APEX2 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 | Xp11.23 | 0.195 | 0.35 | 1.27e-13
|
| TARP | | | 0.194 | 0.052 | 0.284
|
| ZNF354A | zinc finger protein 354A | 5q35.3 | 0.194 | 0.241 | 4.91e-07
|
| C6orf62 | chromosome 6 open reading frame 62 | 6p22.1 | 0.193 | 0.232 | 1.41e-06
|
| RBBP7 | retinoblastoma binding protein 7 | Xp22.22 | 0.193 | 0.363 | 1.13e-14
|
| FAM120C | family with sequence similarity 120C | Xp11.22 | 0.193 | 0.198 | 4.05e-05
|
| PDHA1 | pyruvate dehydrogenase (lipoamide) alpha 1 | Xp22.1 | 0.191 | 0.318 | 2.11e-11
|
| PROS1 | protein S (alpha) | 3q11.1 | 0.19 | -0.271 | 1.52e-08
|
| PARP15 | poly (ADP-ribose) polymerase family, member 15 | 3q21 | 0.188 | 0.112 | 0.0205
|
| KRBOX4 | KRAB box domain containing 4 | Xp11.3 | 0.188 | 0.304 | 1.81e-10
|
| LDHB | lactate dehydrogenase B | 12p12.2-p12.1 | 0.187 | 0.113 | 0.0192
|
| LAS1L | LAS1-like, ribosome biogenesis factor | Xq12 | 0.186 | 0.341 | 6.44e-13
|
| TRIM38 | tripartite motif containing 38 | 6p21.3 | 0.186 | 0.324 | 8.32e-12
|
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 3q25.32 | 0.186 | -0.124 | 0.0103
|
| SHROOM2 | shroom family member 2 | Xp22.3 | 0.184 | 0.271 | 1.39e-08
|
| THOC1 | THO complex 1 | 18p11.32 | 0.183 | 0.242 | 4.53e-07
|
| MEA1 | male-enhanced antigen 1 | 6p21.3-p21.1 | 0.182 | 0.169 | 0.000461
|
| NUPL2 | nucleoporin like 2 | 7p15 | 0.182 | 0.231 | 1.49e-06
|
| RAP2B | RAP2B, member of RAS oncogene family | 3q25.2 | 0.182 | 0.16 | 0.000949
|
| TMSB4XP8 | thymosin beta 4, X-linked pseudogene 8 | 4q22.1 | 0.182 | 0.345 | 2.83e-13
|
| B3GNT2 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | 2p15 | 0.182 | -0.048 | 0.319
|
| METTL7B | methyltransferase like 7B | 12q13.2 | 0.181 | -0.021 | 0.659
|
| VMA21 | VMA21 vacuolar H+-ATPase homolog (S. cerevisiae) | Xq28 | 0.181 | 0.171 | 0.000407
|
| INPP5E | inositol polyphosphate-5-phosphatase E | 9q34.3 | 0.181 | 0.147 | 0.00234
|
| PNPLA4 | patatin-like phospholipase domain containing 4 | Xp22.3 | 0.18 | 0.238 | 6.75e-07
|
| MID1IP1 | MID1 interacting protein 1 | Xp11.4 | 0.179 | 0.241 | 5.01e-07
|
| ATP11C | ATPase, class VI, type 11C | Xq27.1 | 0.177 | 0.208 | 1.5e-05
|
| ZMIZ1-AS1 | ZMIZ1 antisense RNA 1 | 10q22.3 | 0.177 | -0.003 | 0.945
|
| ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | 17q21 | 0.176 | -0.242 | 4.63e-07
|
| ISM2 | isthmin 2 | 14q24.3 | 0.175 | -0.119 | 0.0135
|
| CHIC2 | cysteine-rich hydrophobic domain 2 | 4q12 | 0.174 | 0.215 | 7.85e-06
|
| SLC7A6 | solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 | 16q22.1 | 0.171 | -0.131 | 0.00687
|
| TRANK1 | tetratricopeptide repeat and ankyrin repeat containing 1 | 3p22.2 | 0.171 | 0.132 | 0.00637
|
| ZNRF3 | zinc and ring finger 3 | 22q12.1 | 0.171 | -0.094 | 0.0518
|
| LOC285629 | | | 0.169 | 0.132 | 0.0065
|
| SLC25A6 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 | Xp22.32 and Yp11.3 | 0.168 | 0.183 | 0.000147
|
| BCL2L15 | BCL2-like 15 | 1p13.2 | 0.166 | -0.038 | 0.429
|
| PRPSAP2 | phosphoribosyl pyrophosphate synthetase-associated protein 2 | 17p12-p11.2 | 0.164 | 0.117 | 0.0157
|
| DLEU1 | deleted in lymphocytic leukemia 1 (non-protein coding) | 13q14.3 | 0.163 | -0.132 | 0.00653
|
| VGF | VGF nerve growth factor inducible | 7q22 | 0.162 | -0.152 | 0.00169
|
| CDYL2 | chromodomain protein, Y-like 2 | 16q23.2 | 0.16 | 0.104 | 0.0311
|
| MAFG-AS1 | MAFG antisense RNA 1 (head to head) | 17q25.3 | 0.16 | -0.119 | 0.0142
|
| MAPT | microtubule-associated protein tau | 17q21 | 0.158 | -0.203 | 2.47e-05
|
| PEG10 | paternally expressed 10 | 7q21 | 0.157 | -0.149 | 0.00208
|
| ENTPD2 | ectonucleoside triphosphate diphosphohydrolase 2 | 9q34 | 0.155 | -0.195 | 5.08e-05
|
| TMEM151A | transmembrane protein 151A | 11q13.2 | 0.153 | -0.183 | 0.000142
|
| IFNGR2 | interferon gamma receptor 2 (interferon gamma transducer 1) | 21q22.1 | 0.149 | 0.062 | 0.202
|
| FBXO4 | F-box protein 4 | 5p12 | 0.147 | 0.116 | 0.0165
|
| NYAP1 | neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1 | 7q22.1 | 0.147 | -0.14 | 0.00372
|